Anilkumar Malhotra.
#127,640
Most Influential Person Now
Anilkumar Malhotra.'s AcademicInfluence.com Rankings
Anilkumar Malhotra.biology Degrees
Biology
#8190
World Rank
#11228
Historical Rank
Genetics
#813
World Rank
#905
Historical Rank
Molecular Biology
#1019
World Rank
#1043
Historical Rank
Download Badge
Biology
Anilkumar Malhotra.'s Degrees
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Anilkumar Malhotra. Influential?
(Suggest an Edit or Addition)Anilkumar Malhotra.'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biological Insights From 108 Schizophrenia-Associated Genetic Loci (2014) (6445)
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (2013) (2011)
- Genome-wide association study identifies five new schizophrenia loci (2011) (1680)
- Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals (2018) (1401)
- Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. (1997) (1174)
- Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. (2009) (910)
- Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders (2019) (724)
- Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence (2018) (705)
- Microduplications of 16p11.2 are Associated with Schizophrenia (2009) (685)
- Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) (676)
- Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics (1997) (666)
- NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers (1996) (652)
- A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. (2002) (622)
- Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
- Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. (2004) (444)
- Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function (2018) (417)
- Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect? (2007) (403)
- Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. (1997) (401)
- Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation (2005) (389)
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
- Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia (2007) (354)
- Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. (1999) (353)
- Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia (2002) (337)
- High Frequencies of De Novo CNVs in Bipolar Disorder and Schizophrenia (2011) (308)
- Effects of Ketamine on Thought Disorder, Working Memory, and Semantic Memory in Healthy Volunteers (1998) (301)
- Pharmacogenetics of psychotropic drug response. (2004) (290)
- Antipsychotic drugs and obesity. (2011) (279)
- Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study. (2015) (258)
- Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia. (2015) (246)
- The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. (1996) (241)
- Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. (2001) (237)
- Clinical and Neuropsychological Correlates of White Matter Abnormalities in Recent Onset Schizophrenia (2008) (235)
- Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach (1998) (220)
- High dose D-serine in the treatment of schizophrenia (2010) (210)
- Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder (2015) (206)
- Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. (2013) (205)
- Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine (1997) (203)
- White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. (2005) (201)
- White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. (2005) (200)
- White matter development in adolescence: diffusion tensor imaging and meta-analytic results. (2012) (195)
- D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. (2010) (193)
- Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction (2011) (190)
- Genetic variation in DTNBP1 influences general cognitive ability. (2006) (188)
- Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. (1999) (184)
- Molecular Genetic Evidence for Genetic Overlap between General Cognitive Ability and Risk for Schizophrenia: A Report from the Cognitive Genomics Consortium (COGENT) (2013) (184)
- Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. (2012) (181)
- Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents. (2006) (178)
- GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium (2017) (178)
- Cognitive and symptomatic predictors of functional disability in schizophrenia (2011) (178)
- Early prediction of antipsychotic response in schizophrenia. (2003) (173)
- Association of the DTNBP1 locus with schizophrenia in a U.S. population. (2004) (171)
- The MATRICS Consensus Cognitive Battery in Patients with Bipolar I Disorder (2011) (161)
- Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. (2003) (160)
- Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. (2015) (157)
- DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. (2006) (153)
- Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial (2008) (147)
- Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles (2014) (141)
- Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis. (2016) (135)
- Dopamine D2 receptor density and personal detachment in healthy subjects. (1998) (134)
- COMT genetic variation confers risk for psychotic and affective disorders: a case control study (2005) (133)
- A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics (1998) (132)
- Pharmacogenetics of antipsychotic-induced weight gain (2004) (131)
- Dopamine Transporter Gene Variant Affecting Expression in Human Brain is Associated with Bipolar Disorder (2011) (128)
- Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. (2011) (123)
- Resting-state fMRI connectivity impairment in schizophrenia and bipolar disorder. (2014) (122)
- Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. (1996) (121)
- Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: Evidence of epistasis and competitive binding (2008) (121)
- DTNBP1 genotype influences cognitive decline in schizophrenia (2007) (120)
- Dysbindin genotype and negative symptoms in schizophrenia. (2006) (120)
- The role of myelination in measures of white matter integrity: Combination of diffusion tensor imaging and two-photon microscopy of CLARITY intact brains (2017) (118)
- Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels (2006) (116)
- Early identification and high-risk strategies for bipolar disorder. (2007) (114)
- Neurocognition as a Stable Endophenotype in Bipolar Disorder and Schizophrenia (2006) (111)
- Age-Related Differences in White Matter Tract Microstructure Are Associated with Cognitive Performance from Childhood to Adulthood (2014) (110)
- DISC1 and neurocognitive function in schizophrenia (2005) (108)
- White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis (2014) (107)
- Genetic correlation between amyotrophic lateral sclerosis and schizophrenia (2017) (107)
- A Voxel-Based Diffusion Tensor Imaging Study of White Matter in Bipolar Disorder (2008) (104)
- Sex differences in resilience to childhood maltreatment: effects of trauma history on hippocampal volume, general cognition and subclinical psychosis in healthy adults. (2013) (102)
- Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. (2019) (102)
- Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder (2013) (102)
- DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia (2008) (101)
- The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response (1998) (99)
- Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia (2007) (98)
- COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. (2007) (98)
- Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. (2006) (98)
- A Schizophrenia Risk Gene, ZNF804A, Influences Neuroanatomical and Neurocognitive Phenotypes (2010) (98)
- Effects of Serotonin Transporter Promoter Polymorphisms on Serotonin Function (2004) (97)
- A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. (2015) (97)
- Benefits and pitfalls encountered in psychiatric genetic association studies (1999) (96)
- Interaction between FEZ1 and DISC1 in Regulation of Neuronal Development and Risk for Schizophrenia (2011) (94)
- A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. (2011) (93)
- Sex differences in frontal lobe white matter microstructure: a DTI study (2003) (93)
- Complement genes contribute sex-biased vulnerability in diverse illnesses (2020) (92)
- Large-scale cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets (2017) (92)
- The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia. (2008) (85)
- Temperament and character dimensions in bipolar I disorder: a comparison to healthy controls. (2008) (84)
- DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia. (2010) (83)
- White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study (2019) (83)
- Disrupted in Schizophrenia 1 Genotype and Positive Symptoms in Schizophrenia (2007) (82)
- Clozapine response and the 5HT2C Cys23Ser polymorphism (1996) (78)
- Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis. (2015) (77)
- Cannabis and cognitive functions: a prospective study. (1988) (77)
- Molecular Characterization of Echinococcus granulosus Cysts in North Indian Patients: Identification of G1, G3, G5 and G6 Genotypes (2013) (76)
- Effect of Acute Metabolic Stress on Pituitary-Adrenal Axis Activation in Patients With Schizophrenia (1998) (75)
- A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents. (2004) (74)
- Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways (2019) (71)
- The Role of COMT Val158Met in Cognition (2009) (69)
- Pharmacogenetics of antipsychotic-induced side effects (2009) (69)
- Adverse Effects of Antipsychotic Drugs (1993) (68)
- Cognitive Dysfunction in Bipolar Disorder (2007) (67)
- Relationship among interthalamic adhesion size, thalamic anatomy and neuropsychological functions in healthy volunteers (2017) (67)
- Cases of buprenorphine abuse in India (1992) (66)
- Implication of a rare deletion at distal 16p11.2 in schizophrenia. (2013) (66)
- Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis. (2013) (66)
- 5HT2a receptor T102C polymorphism and schizophrenia (1996) (65)
- Cannabis use disorders in schizophrenia: Effects on cognition and symptoms (2010) (65)
- White Matter Abnormalities in Pediatric Obsessive-Compulsive Disorder (2012) (63)
- Spectrum of EEG abnormalities during clozapine treatment. (1994) (62)
- Greater Extracellular Free Water in First-Episode Psychosis Predicts Better Neurocognitive Functioning (2017) (62)
- Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients. (1996) (62)
- Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis (2018) (62)
- Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. (2012) (61)
- Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. (2015) (61)
- In Vivo MicroRNA Detection and Quantitation in Cerebrospinal Fluid (2012) (60)
- A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts (2020) (60)
- Abnormal cingulum bundle development in autism: A probabilistic tractography study (2014) (60)
- Abuse of codeine-containing cough syrups: a report from India. (1997) (60)
- Pharmacogenetics of antipsychotics: recent progress and methodological issues (2013) (59)
- Comparative study of neurological soft signs in schizophrenia with onset in childhood, adolescence and adulthood (2007) (58)
- New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. (2015) (58)
- Fine mapping of ZNF 804 A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder (2011) (57)
- Gray matter structural alterations in obsessive–compulsive disorder: Relationship to neuropsychological functions (2008) (56)
- Mechanism of Peripheral Noradrenergic Stimulation by Clozapine (1998) (56)
- The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised. (2000) (56)
- Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia (2009) (56)
- Judgements of agency in schizophrenia: an impairment in autonoetic metacognition (2012) (56)
- Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene (2012) (56)
- Schizophrenia polygenic risk score and 20-year course of illness in psychotic disorders (2019) (55)
- CHILDHOOD PSYCHOPATHOLOGY MEAUSREMENT SCHEDULE: DEVELOPMENT AND STANDARDIZATION* (1988) (55)
- Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia (2013) (54)
- Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality. (2009) (53)
- EXTENT AND PATTERN OF ALCOHOL USE AND ALCOHOL-RELATED PROBLEMS IN NORTH INDIA* (1980) (53)
- Relationship between Duration of Untreated Psychosis and Intrinsic Corticostriatal Connectivity in Patients with Early Phase Schizophrenia (2017) (53)
- Genomics and the future of pharmacotherapy in psychiatry (2007) (53)
- Emotional modulation of response inhibition in stable patients with bipolar I disorder: a comparison with healthy and schizophrenia subjects (2011) (52)
- The serotonin transporter gene and disease modification in psychosis: Evidence for systematic differences in allelic directionality at the 5-HTTLPR locus (2009) (51)
- Implications for health and disease in the genetic signature of the Ashkenazi Jewish population (2012) (49)
- Evidence from structural and diffusion tensor imaging for frontotemporal deficits in psychometric schizotypy. (2015) (48)
- Clinical and cognitive correlates of suicide attempts in bipolar disorder: is suicide predictable? (2011) (48)
- Comparative study of neuropsychological correlates in schizophrenia with onset in childhood, adolescence and adulthood (2006) (47)
- Cannabis Psychosis and Acute Schizophrenia (1999) (47)
- The Relationship of Common Risk Variants and Polygenic Risk for Schizophrenia to Sensorimotor Gating (2016) (46)
- Individualizing antipsychotic drug therapy in schizophrenia: The promise of pharmacogenetics (2007) (46)
- The COMT Met158 allele and violence in schizophrenia: A meta-analysis (2012) (46)
- A resting state fMRI analysis pipeline for pooling inference across diverse cohorts: an ENIGMA rs-fMRI protocol (2018) (46)
- Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia. (2009) (45)
- Meta-Analysis of Genetic Variation in DTNBP1 and General Cognitive Ability (2010) (45)
- The relation between childhood maltreatment and psychosis in patients with schizophrenia and non-psychiatric controls (2014) (45)
- Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia (2013) (45)
- Novel multi-nucleotide polymorphisms in the human genome characterized by whole genome and exome sequencing (2010) (45)
- The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males (2014) (44)
- A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone (2019) (44)
- The SORL1 Gene and Convergent Neural Risk for Alzheimer's Disease Across the Human Lifespan (2013) (44)
- Abnormal Temporal Lobe White Matter as a Biomarker for Genetic Risk of Bipolar Disorder (2013) (44)
- Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. (2015) (43)
- Impulsivity in bipolar disorder: relationships with neurocognitive dysfunction and substance use history (2013) (43)
- Correlates of early- and late-onset alcohol dependence. (1994) (43)
- Patterns of stress in schizophrenia (2008) (43)
- Age and sex effects on corpus callosum morphology across the lifespan (2015) (43)
- Independent component analysis of resting state activity in pediatric obsessive‐compulsive disorder (2014) (42)
- Lack of gender differences in neuroleptic response in patients with schizophrenia (1996) (42)
- Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder (2013) (42)
- Electric field causes volumetric changes in the human brain (2019) (41)
- Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. (2009) (41)
- Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis. (2020) (40)
- Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability. (2010) (40)
- Neurocognitive profile analysis in obsessive-compulsive disorder (2008) (39)
- The role of general intelligence as an intermediate phenotype for neuropsychiatric disorders (2009) (39)
- Attention and psychomotor functioning in bipolar depression (2009) (37)
- Dietary pattern and nutritional deficiencies among urban adolescents (2015) (36)
- Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder (2012) (36)
- Metabolism and biochemical effects of nicotine for primary care providers. (2004) (36)
- Genetic variation in the DAOA gene complex: Impact on susceptibility for schizophrenia and on cognitive performance (2008) (35)
- Cannabis and cognitive functions: a re-evaluation study. (1988) (35)
- Electroconvulsive Therapy and Schizophrenia: A Systematic Review (2019) (34)
- DTNBP1 is associated with imaging phenotypes in schizophrenia (2009) (33)
- The accumbofrontal tract: Diffusion tensor imaging characterization and developmental change from childhood to adulthood (2015) (33)
- Stress-Dependent Association Between Polygenic Risk for Schizophrenia and Schizotypal Traits in Young Army Recruits (2018) (33)
- Genome‐wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness (2016) (32)
- Cannabis psychosis and acute schizophrenia. a case-control study from India. (1999) (32)
- Assessment of physical disability using Barthel index among elderly of rural areas of district Jhansi (U.P), India (2016) (31)
- Dopaminergic Influences on Emotional Decision Making in Euthymic Bipolar Patients (2014) (31)
- GWAS meta-analysis (N=279,930) identifies new genes and functional links to intelligence (2017) (31)
- A polygenic resilience score moderates the genetic risk for schizophrenia (2019) (31)
- Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis (2016) (30)
- Genome-wide autozygosity is associated with lower general cognitive ability (2016) (30)
- Increased stress and smaller anterior hippocampal volume (2006) (29)
- Coding and Noncoding Gene Expression Biomarkers in Mood Disorders and Schizophrenia (2013) (29)
- Transcranial Magnetic Stimulation for Positive Symptoms in Schizophrenia: A Systematic Review (2019) (29)
- Changes in Body Mass and Metabolic Profiles in Patients with First-Episode Schizophrenia Treated for 12 Months with A First-Generation Antipsychotic (2015) (28)
- Independent evidence for an association between general cognitive ability and a genetic locus for educational attainment (2015) (27)
- The FEZ1 Gene Shows No Association to Schizophrenia in Caucasian or African American Populations (2007) (26)
- Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults (2017) (26)
- Complement genes contribute sex-biased vulnerability in diverse disorders (2020) (25)
- Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection (2018) (25)
- Brain White Matter Development Is Associated with a Human-Specific Haplotype Increasing the Synthesis of Long Chain Fatty Acids (2014) (25)
- Evidence for impaired visual prediction error in schizophrenia (2013) (25)
- Delineation of hippocampal subregions using T1-weighted magnetic resonance images at 3 Tesla (2015) (24)
- QT interval duration and dispersion in children and adolescents treated with ziprasidone. (2011) (24)
- Recent Progress in Pharmacogenomics of Antipsychotic Drug Response (2018) (24)
- BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: A meta-analysis (2014) (24)
- Apolipoprotein E ε4 and clinical phenotype in schizophrenia (1997) (23)
- Adding insult to injury: Childhood and adolescent risk factors for psychosis predict lower fractional anisotropy in the superior longitudinal fasciculus in healthy adults (2014) (23)
- A longitudinal study of male buprenorphine addicts attending an addiction clinic in India. (2000) (22)
- COMT genotype and manic symptoms in schizophrenia (2006) (22)
- Lower- and Higher-Level Social Cognitive Factors Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls: Relationship With Neurocognition and Functional Outcome (2018) (22)
- A cross sectional study on depression, anxiety and their associated factors among medical students in Jhansi, Uttar Pradesh, India (2016) (22)
- Single-subject classification of schizophrenia using event-related potentials obtained during auditory and visual oddball paradigms (2013) (21)
- Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders (2021) (21)
- A schizophrenia risk gene, ZNF804A, is associated with brain white matter microstructure (2014) (21)
- Pharmacogenomics and schizophrenia: clinical implications (2001) (21)
- Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis (2014) (21)
- Age‐associated alterations in corpus callosum white matter integrity in bipolar disorder assessed using probabilistic tractography (2015) (21)
- SENSATION SEEKING SCALE: INDIAN ADAPTATION (1993) (20)
- Age-Normative Pathways of Striatal Connectivity Related to Clinical Symptoms in the General Population (2019) (20)
- Analysis of TBX1 Variation in Patients with Psychotic and Affective Disorders (2007) (19)
- Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia (2015) (19)
- Separable and Replicable Neural Strategies During Social Brain Function in People With and Without Severe Mental Illness. (2019) (19)
- Non-organic chronic intractable pain: A comparative study (1984) (18)
- A longitudinal human phantom reliability study of multi-center T1-weighted, DTI, and resting state fMRI data (2018) (18)
- Why Not Clozapine (2007) (18)
- Integration of routine QA data into mega‐analysis may improve quality and sensitivity of multisite diffusion tensor imaging studies (2018) (18)
- MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults (2014) (18)
- Corrigendum: GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function (2017) (17)
- Erratum: GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium (2017) (17)
- The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project (2017) (17)
- Discovery and utilization of haplotypes for pharmacogenetic studies of psychotropic drug response. (2002) (17)
- ILLNESS BEHAVIOUR QUESTIONNAIRE (IBQ): TRANSLATION AND ADAPTATION IN INDIA (1986) (17)
- Excess of homozygosity in the major histocompatibility complex in schizophrenia. (2014) (17)
- Pharmacogenetic Approaches to Cognitive Enhancement in Schizophrenia (2011) (17)
- Emotional bias in unaffected siblings of patients with bipolar I disorder. (2012) (17)
- Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects (2009) (17)
- Ziprasidone-induced cognitive enhancement in schizophrenia: Specificity or pseudospecificity? (2006) (17)
- Diffusion tensor imaging measures of white matter compared to myelin basic protein immunofluorescence in tissue cleared intact brains (2016) (17)
- Relapse Precipitants, Life events and Dysfunction in alcohol and opioid dependent men (2003) (17)
- Effects of Atypical Antipsychotic Drug Treatment on Amphetamine-Induced Striatal Dopamine Release in Patients with Psychotic Disorders (1999) (16)
- D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patients. (1997) (16)
- The pharmacogenetics of depression: enter the GWAS. (2010) (16)
- White Matter Abnormalities Associated With Subsyndromal Psychotic-Like Symptoms Predict Later Social Competence in Children and Adolescents (2017) (16)
- White matter microstructure in the executive network associated with aggression in healthy adolescents and young adults. (2015) (16)
- CANNABIS RELATED PSYCHIATRIC SYNDROMES: A SELECTIVE REVIEW (1994) (15)
- Complement component C4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia (2020) (15)
- Patterns of variation influencing antipsychotic treatment outcomes in South African first-episode schizophrenia patients. (2014) (15)
- Structural similarity networks predict clinical outcome in early-phase psychosis (2019) (15)
- The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients (2016) (15)
- Severe babesiosis and Borrelia burgdorferi co-infection. (2015) (15)
- The future of pharmacotherapy for schizophrenia. (2003) (15)
- Informed consent in schizophrenia research. (1998) (14)
- Parasympathetic arousal-related cortical activity is associated with attention during cognitive task performance (2019) (14)
- Genome‐wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder (2019) (14)
- PSYCHIATRIC ASPECTS OF CHRONIC INTRACTABLE PAIN (1983) (14)
- The Apolipoprotein E ε4 Allele Is Associated with Blunting of Ketamine-Induced Psychosis in Schizophrenia: A Preliminary Report (1998) (14)
- Healthy Adolescent Performance With Standardized Scoring Tables for the MATRICS Consensus Cognitive Battery: A Multisite Study (2018) (13)
- Safety profile of iloperidone in the treatment of schizophrenia (2014) (13)
- The dopamine D(4) receptor gene and novelty seeking. (2000) (13)
- Psychosocial Treatment of Substance Use Disorders in Adolescents (2005) (13)
- Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia—a multicenter harmonized diffusion tensor imaging study (2021) (13)
- Neural Activity while Imitating Emotional Faces is Related to Both Lower and Higher-Level Social Cognitive Performance (2017) (13)
- Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes. (2016) (13)
- Comparison of Quality of Life in Patients Undergoing Transhiatal Esophagectomy with or without Chemotherapy (2012) (13)
- Visual fixation deficits and evidence of cognitive impairment in schizophrenia (1992) (13)
- Ninety-nine independent genetic loci influencing general cognitive function include genes associated with brain health and structure (N = 280,360) (2017) (12)
- Positive and negative subclinical symptoms and MCCB performance in non-psychiatric controls (2014) (12)
- Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia (2015) (12)
- Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT‐deleted (DM) tau mouse model (2018) (12)
- Social cognition in patients with schizophrenia spectrum and bipolar disorders with and without psychotic features☆ (2015) (12)
- Investigating Sexual Dimorphism of Human White Matter in a Harmonized, Multisite Diffusion Magnetic Resonance Imaging Study. (2020) (12)
- Amphetamine-Induced Dopamine Release and Post-Synaptic Specific Binding in Patients with Mild Tardive Dyskinesia (2001) (12)
- Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain (2009) (12)
- Subtypes of codeine cough syrup abusers. (1999) (11)
- Postnatal neurodevelopmental expression and glutamate-dependent regulation of the ZNF804A rodent homologue (2015) (11)
- Investigation of superior longitudinal fasciculus fiber complexity in recent onset psychosis (2018) (11)
- Cerebrospinal fluid monoamine metabolites in childhood-onset schizophrenia. (1997) (11)
- Novel ultra-rare exonic variants identified in a founder population implicate cadherins in schizophrenia (2020) (11)
- Striatal volume and functional connectivity correlate with weight gain in early-phase psychosis (2019) (10)
- Can genetics inform the management of cognitive deficits in schizophrenia? (2012) (10)
- Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence (2017) (10)
- Auditory Evoked Responses in Clinical Practice (1997) (10)
- Depression in general clinical practice--a diagnostic problem. (1995) (10)
- Pseudoaneurysm in injecting drug abusers: cases from India. (1994) (10)
- Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine. (2013) (10)
- Abnormal Resting State fMRI Activity Predicts Processing Speed Deficits in First-Episode Psychosis (2015) (10)
- DEVELOPMENT OF A SCALE TO ASSESS ATTITUDES TOWARD DRINKING AND ALCOHOLISM (1998) (10)
- Discovery of Genetic Markers Associated with Clozapine Induced Agranulocytosis. (2005) (10)
- Genome-wide association study implicates NDST 3 in schizophrenia and bipolar disorder (2013) (10)
- Responses to Tobacco Smoking-Related Health Messages in Young People With Recent-Onset Schizophrenia. (2015) (10)
- A Comparative Study of Clinical Correlates in Schizophrenia with Onset in Childhood, Adolescence and Adulthood (2006) (10)
- The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report. (1998) (9)
- The Clinical and Demographic Profile of Nicotine Users Among Children and Adolescents (2009) (9)
- Abnormal anterior cingulate cortex activity predicts functional disability in schizophrenia (2012) (9)
- Age and Sex Effects on White Matter Tracts in Psychosis from Adolescence through Middle Adulthood (2016) (9)
- In Support of Neuroimaging Biomarkers of Treatment Response in First-Episode Schizophrenia. (2016) (9)
- Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System (2022) (9)
- Pharmacogenetics of Psychotropic Drugs: From pharmacogenetics to pharmacogenomics of psychotropic drug response (2002) (9)
- Cannabis Use and Performance in Adolescents (2006) (9)
- Genome-wide Association Study of Clinical Features in the Schizophrenia Psychiatric Genomics Consortium: Confirmation of Polygenic Effect on Negative Symptoms (2017) (9)
- Improving the predictive potential of diffusion MRI in schizophrenia using normative models—Towards subject‐level classification (2021) (8)
- ECT-induced cognitive side effects are associated with hippocampal enlargement (2021) (8)
- History of childhood maltreatment is associated with reduced fractional anisotropy of the accumbofrontal ‘reward’ tract in healthy adults (2020) (8)
- The field of schizophrenia: strengths, weaknesses, opportunities, and threats. (2012) (8)
- Antipsychotic polypharmacy in the treatment of schizophrenia (2003) (8)
- Clinical and pharmacogenetic studies of iloperidone. (2008) (8)
- Sex-Dependent Shared and Non-Shared Genetic Architecture Across Mood and Psychotic Disorders (2020) (8)
- Classification of Acute Nonorganic Psychotic States in India (1992) (8)
- Author Correction: Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function (2019) (7)
- Clonidine versus Withdrawal Using an Opioid in In-Patient Opioid Detoxification (1997) (7)
- Genetics of schizophrenia: What do we know? (2013) (7)
- Dopamine D 2 receptor genetic variation and clinical response to antipsychotic drug treatment : A meta-analysis (2010) (7)
- Effects of passive smoking (environmental tobacco smoke) on pregnancy outcome at district hospital, Jhansi, Uttar Pradesh - (2015) (7)
- Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood (2019) (7)
- A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort) (2020) (6)
- No evidence for phenotypic variation between probands in case-control versus family-based association studies of schizophrenia. (2002) (6)
- Deconstructing Avolition: Initiation vs persistence of reward-directed effort (2019) (6)
- SOCIODEMOGRAPHIC STUDY OF PATIENTS WITH CHRONIC PAIN (1986) (6)
- Acceptability of Naltrexone by Patients with Opioid Dependence: an Indian Perspective (2003) (6)
- THE SENSATION - SEEKER WHO IS ALSO ALIENATED: TOWARDS A NEW HYPOTHESIS FOR GENESIS OF OPIATE ADDICTION (1995) (6)
- Social Cognitive Networks and Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Control Participants. (2020) (6)
- Genetics and psychopharmacology: prospects for individualized treatment. (2005) (6)
- Variation within voltage-gated calcium channel genes and antipsychotic treatment response in a South African first episode schizophrenia cohort (2018) (6)
- Homoeopathic medicinal treatment of autism (2010) (6)
- Subcortical modulation in auditory processing and auditory hallucinations (2015) (6)
- Empirical Support for DSM-IV Schizoaffective Disorder: Clinical and Cognitive Validators from a Large Patient Sample (2013) (6)
- Analysis of TBX 1 Variation in Patients with Psychotic and Affective Disorders (2007) (6)
- Pharmacogenetics in mood disorder (2005) (6)
- Functional Activation During a Cognitive Control Task in Healthy Youth Specific to Externalizing or Internalizing Behaviors. (2017) (6)
- Predicting Response to Clozapine (1999) (5)
- A Common Polymorphism in SCN2A Predicts General Cognitive Ability through Effects on PFC Physiology (2015) (5)
- Pharmacogenetics in Psychiatry Satellite Meeting at the American College of Neuropsychopharmacology, 2000 (2002) (5)
- Molecular Genetics of the Psychosis Phenotype (2012) (5)
- The 8th Annual Pharmacogenetics in Psychiatry Meeting Report (2009) (5)
- Molecular Genetics of the Psychosis Phenotype (2012) (5)
- Striatal functional connectivity in psychosis relapse: A hypothesis generating study (2021) (5)
- Interferon-induced obsessive-compulsive disorder. (2006) (5)
- THE AGORAPHOBIC ALCOHOLIC: REPORT OF TWO CASES (1993) (5)
- A 16-week randomized placebo-controlled trial investigating the effects of omega-3 polyunsaturated fatty acid treatment on white matter microstructure in recent-onset psychosis patients concurrently treated with risperidone (2020) (5)
- Single point mutation on the gene encoding dysbindin results in recognition deficits (2018) (5)
- The relevance of pharmacogenetics to schizophrenia (2003) (5)
- NATIONAL POLICIES TO MEET THE CHALLENGE OF SUBSTANCE ABUSE : PROGRAMMES AND IMPLEMENTATION (2000) (5)
- A STUDY ON KNOWLEDGE, ATTITUDE AND PRACTICES REGARDING DENGUE FEVER AMONG PEOPLE LIVING IN URBAN AREA OF JHANSI CITY (UP) (2014) (4)
- MOTIVATION FOR ADDICTION TREATMENT-HINDI SCALE: DEVELOPMENT AND FACTOR STRUCTURE (2002) (4)
- M41 IDENTIFYING NOOTROPIC DRUG TARGETS VIA LARGE-SCALE COGNITIVE GWAS AND TRANSCRIPTOMICS (2019) (4)
- A Study on Prevalence of Practice of Universal Precautions Among Health Care Workers in Medical College, Jhansi (U.P) (2015) (4)
- White Matter Abnormalities in Obsessive-compulsive Disorder (2005) (4)
- Biologic Predictors of Clozapine Response in Schizophrenia (1996) (4)
- Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study. (2019) (4)
- Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics (2020) (4)
- COMT and neurocognition: New evidence for a role in visual memory (2003) (4)
- THE BRIEF PSYCHIATRIC RATING SCALE IN POSITIVE AND NEGATIVE SUBTYPES OF SCHIZOPHRENIA (1987) (4)
- Genetic Factors and Neurocognitive Traits (2002) (4)
- F10. DIFFERENTIAL EXPRESSION OF MICRORNAS IN CEREBROSPINAL FLUID AND PLASMA SAMPLES IN SCHIZOPHRENIA (2018) (4)
- Psychiatric symptoms in patients with non-organic chronic intractable pain. (1991) (4)
- HIV screening & risk behaviour in psychoactive substance users. (1993) (4)
- Interaction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response (2020) (4)
- Prevalence of internet addiction and its association with socio-demographic factors among MBBS students at medical college, Jhansi, Uttar Pradesh (2018) (4)
- Towards a framework to develop neuroimaging biomarkers of relapse in schizophrenia (2021) (4)
- Multi-Trait Analysis of GWAS and Biological Insights Into Cognition: A Response to Hill (2018) (2018) (3)
- Clinical and computational speech measures are associated with social cognition in schizophrenia spectrum disorders (2022) (3)
- Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. (1997) (3)
- The 12th Annual Pharmacogenetics in Psychiatry meeting report. (2011) (3)
- Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: A randomized clinical trial (2021) (3)
- Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study (2022) (3)
- MCPH1 is associated with risk for illness and cognitive ability in patients with schizophrenia (2007) (3)
- A Study of Chemical Composition of Gall Stones in a Tertiary Care Hospital (2020) (3)
- Pharmacogenomics of Antipsychotic Drugs (2017) (3)
- Common Variants near the Melanocortin 4 Receptor Gene are Associated with Severe Antipsychotic Drug-induced Weight Gain (2014) (3)
- THE MANAGEMENT OF ALCOHOL-RELATED PROBLEMS IN GENERAL PRACTICE IN NORTH INDIA (1988) (2)
- Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (2019) (2)
- Affective modulation of target detection in deficit and non-deficit schizophrenia (2019) (2)
- Pattern of ocular trauma at MLB Medical College, Jhansi (UP) - A retrospective study (2015) (2)
- Clinical insights into pharmacogenetics and schizophrenia, part 2. (2008) (2)
- Alexithymia - Brief Review And A Study In Chronic Pain Patients ∗ (1984) (2)
- Contributions of parasympathetic arousal-related activity to cognitive performance in First Episode Psychosis patients and controls. (2021) (2)
- A simulations approach for meta-analysis of genetic association studies based on additive genetic model. (2016) (2)
- The State of Pharmacogenetics Customizing Treatments (2010) (2)
- Real-world functioning in schizophrenia: pathways between neurocognition, social cognition, and functional competence (2013) (2)
- POPULAR ATTITUDES TOWARDS ALCOHOL USE AND ALCOHOLISM* (1981) (2)
- Alcoholism and Substance Abuse: Recent Trends in Intervention (1996) (2)
- Poster #103 COMT MET158 ALLELE IS ASSOCIATED WITH VIOLENCE IN SCHIZOPHRENIA: A META-ANALYSIS (2012) (2)
- In-depth Analysis of Pattern of Occupational Injuries and Utilization of Safety Measures among Workers of Railway Wagon Repair Workshop in Jhansi (U.P.) (2017) (2)
- A longitudinal multi-scanner multimodal human neuroimaging dataset (2022) (2)
- 296. NMDA receptor function and schizophrenia: Studies with ketamine (1996) (2)
- A cross-sectional study on exclusive breastfeeding practice among lactating females attending medical college, district Jhansi (U.P) - (2017) (2)
- Sex differences in the effect of childhood emotional abuse on hippocampal volume (2013) (2)
- A STUDY ON PREVALENCE AND SEASONAL VARIATION OF DIARRHEAL DISEASES AMONG UNDER-FIVE CHILDREN OF JHANSI, UTTAR PRADESH, INDIA. (2017) (1)
- Pharmacogenomics Applications in Psychiatric Disorders (2008) (1)
- A cross sectional study on refractive errors among adolescentsvisiting medical college, Jhansi, UttarPradesh (2016) (1)
- Implications for health and disease in the genetic signature of the Ashkenazi Jewish population (2012) (1)
- What Is Necessary to Enhance Development and Utilization of Treatment (2013) (1)
- GeneS and Schizophrenia Genes and Schizophrenia : From a Festschrift Seminar honoring (2014) (1)
- How responsible is responsible drinking: An evidence based review (2006) (1)
- Neuroanatomical localization of NMDA receptor-mediated psychosis in healthy controls and schizophrenic patients (1995) (1)
- Characterization of the extracellular free water signal in schizophrenia using multi-site diffusion MRI harmonization. (2023) (1)
- 125. Social Cognitive Network Connectivity is Associated With Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls (2019) (1)
- Striatal volume and functional connectivity predict weight gain in early-phase psychosis (2018) (1)
- Striatal Functional Connectivity in Psychosis Relapse: A Comparison Between Antipsychotic Adherent and Non-Adherent Patients at the Time of Relapse (2020) (1)
- Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD. (2014) (1)
- The Role of Striatal Functional Connectivity in Predicting Response to Clozapine (2020) (1)
- Ultra-Rare Exonic Variants Identified in a Founder Population Implicate Cadherins and Protocadherins in Schizophrenia (2021) (1)
- Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Schizophrenia Spectrum Disorders and Healthy Controls (2018) (1)
- The Ninth Annual Pharmacogenetics in Psychiatry Meeting report. (2011) (1)
- A CROSS-SECTIONAL STUDY ON PREVALENCE OF PRETERM BIRTH IN MEDICAL COLLEGE JHANSI (U.P.) (2018) (1)
- Skewing of the antibody repertoire in cerebrospinal fluid B cells from healthy controls and patients with schizophrenia (2022) (1)
- The genetics of schizophrenia (2001) (1)
- The effects of lorazepam on cortico-striatal connectivity in schizophrenia (2020) (1)
- 52. Reverse pharmacogenetics: a new approach to rapid relapse in schizophrenia? (2000) (1)
- 608 The NMDA receptor and schizophrenia: From phenotype to genotype (1997) (1)
- Temperament of Children of Addicts: A Preliminary Report (1993) (1)
- BRIEF INTERVENTIONS IN SUBSTANCE ABUSE (2000) (1)
- Cannabinoids and bipolar disorder (2015) (1)
- Cannabinoids and bipolar disorder (2015) (1)
- Pharmacogenetics of antipsychotic drug response (2014) (1)
- 156. Reduced Dysbindin Protein and Behavioral Abnormalities in Mice with a Single Point Mutation on the Schizophrenia Risk Gene DTNBP1 (2017) (1)
- The effects of neuroleptic dose adjustment on D2 receptor occupancy and schizophrenic symptomatology, a study using IBZM spect (1994) (1)
- 415. Effects of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia (1998) (1)
- Pramipexole to Improve Cognition in Bipolar Disorder (2021) (1)
- 5HT 2a receptor T102C polymorphism and schizophrenia. (1996) (1)
- Intractable Seizure in a Case of Primary Amoebic Meningoencephalitis caused by the Free Living Amoeba Naegleria Fowleri (2017) (1)
- S245. LOWER- AND HIGHER-LEVEL SOCIAL COGNITIVE FACTORS ACROSS INDIVIDUALS WITH SCHIZOPHRENIA SPECTRUM DISORDERS AND HEALTHY CONTROLS: RELATIONSHIP WITH NEUROCOGNITION AND FUNCTIONAL OUTCOME (2018) (0)
- Effects of phase encoding direction on test-retest reliability of human functional connectome (2023) (0)
- Towards a Molecular Classification of Illness: Effects of Schizophrenia Susceptibility Loci on Clinical Symptoms and Cognitive Function (2008) (0)
- The effects of ketamine on behavioral, cognitive and neuroendocrine function in schizophrenia (1994) (0)
- In Vivo MicroRNA Detection and Quantitation in Cerebrospinal Fluid (2012) (0)
- The Differential Impact of Childhood Maltreatment on Verbal Learning in Psychosis Patients Vs. Healthy Controls (2020) (0)
- S189. Lower- and Higher-Level Factors of Social Cognition Relate to Neurocognition and Functional Outcome Across Schizophrenia Spectrum Disorders and Healthy Controls (2018) (0)
- Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence (2018) (0)
- PHARMACOGENOMIC APPROACHES TO RARE AND COMMON SIDE EFFECTS ASSOCIATED WITH ANTIPSYCHOTIC DRUG TREATMENT (2010) (0)
- Gene brain structure relationships: arbitrary assumptions of heterogeneity generate unfalsifiable claims. (2007) (0)
- Heritability of Bipolar Disorder (2014) (0)
- Authors' reply (2009) (0)
- 498 Assessment of synaptic dopamine concentrations in schizophrenia with pet (1997) (0)
- Beyond the GWAS in schizophrenia (2011) (0)
- T155. SEPARABLE AND REPLICABLE NEURAL STRATEGIES DURING SOCIAL BRAIN FUNCTION IN PEOPLE WITH AND WITHOUT SEVERE MENTAL ILLNESS (2018) (0)
- Cognitive Deficits and Their White Matter Correlates in Schizophrenia (2021) (0)
- Resting state network changes in pediatric OCD (2011) (0)
- Imaging Genetics of Pharmacological Response in Psychiatric Disorders (2016) (0)
- 34.2 SOCIAL COGNITIVE NETWORK CONNECTIVITY SUPPORTS A NETWORK EFFICIENCY MODEL FOR BETTER SOCIAL COGNITIVE PERFORMANCE ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS AND HEALTHY CONTROLS (2019) (0)
- Baseline FALFF Derived From Resting-State fMRI Predicts Acute Treatment Response in First Episode Psychosis (2021) (0)
- P517. Aggression and Social Cognition in Schizophrenia Spectrum Disorders (2022) (0)
- P303. Personalizing Electroconvulsive Therapy With Electrical Field Modeling (2022) (0)
- Variation within voltage-gated calcium channel genes and antipsychotic treatment response in a South African first episode schizophrenia cohort (2018) (0)
- Proinflammatory cytokines, microRNAs and schizophrenia (2014) (0)
- Psychosis Relapse During Long-Acting Injectable Antipsychotic Treatment: An Individual Participant Data Meta-Analysis of 19 Trials and 5,111 Individuals with Schizophrenia-Spectrum Disorders (2020) (0)
- A Cross Sectional Study on Hypertension And its Association With Smoking Among Elderly In Urban Area of District Jhansi (U.p.) (2016) (0)
- MODULATION OF DOPAMINE USING A D2/D3 AGONIST IN PATIENTS WITH BIPOLAR DISORDER: EFFECTS ON COGNITION AND REWARD PROCESSING (2014) (0)
- Prevalence of Non-Alcoholic Fatty Liver with Gall Stones Disease in Himalayan Population (2020) (0)
- From the Genome to the Connectome: Biomarkers of Behavioral Phenotypes in Psychosis (2020) (0)
- Identification of candidate genes associated with human cognitive variation: Perspectives, problems and pitfalls (2004) (0)
- 81. Relationship Between Untreated Psychosis and Intrinsic Corticostriatal Connectivity in Patients With Recent-Onset Schizophrenia (2017) (0)
- A rare deletion at distal 16 p 11 . 2 is implicated in schizophrenia (2013) (0)
- P514. Excess of Homozygous Ultra-Rare Exonic Variants in Schizophrenia: Evidence for Recessive Effects (2022) (0)
- Neuroanatomical localization of ketamine-induced psychosis in schizophrenic patients and controls (1994) (0)
- O35. Relationship of Rich Club Organization and MCCB Reasoning Domain in First Episode Schizophrenia (2019) (0)
- VKučinskas-2001-2016 (2016) (0)
- PHENOMENOLOGICAL DIFFERENCES BETWEEN HISPANIC AND CAUCASIAN SCHIZOPHRENIA SUBJECTS (2010) (0)
- S43. ASSESSING THE VARIABILITY OF RESPONSE TO NON-INVASIVE BRAIN STIMULATION IN PSYCHOSIS (2020) (0)
- GWAS meta-analysis (N=279,930) identifies new genes and functional links to general cognitive ability (2018) (0)
- The Third Annual Pharmacogenetics in Psychiatry Meeting, 2004. (2005) (0)
- Structural and Functional Neuroimaging Biomarkers of Antipsychotic Treatment Response in Early-Course and Chronic Schizophrenia (2020) (0)
- A resting state fMRI analysis pipeline for pooling inference across diverse cohorts: an ENIGMA rs-fMRI protocol (2018) (0)
- M19. NIGROSTRIATAL CONNECTIVITY AND THE PREDICTION OF THOUGHT DISTURBANCE IN EARLY PSYCHOSIS (2020) (0)
- 403. Investigation of Superior Longitudinal Fasciculus Fiber Complexity in Recent-Onset Psychosis (2017) (0)
- Pharmacogenetics of Antipsychotic-Induced Weight Gain in Multiple Medication-Naive Cohorts (2017) (0)
- S121. REAL-WORLD FUNCTIONING IN SCHIZOPHRENIA: NEGATIVE SYMPTOMS AS A BRIDGE IN PATHWAYS FROM NEUROCOGNITION, SOCIAL COGNITION, AND FUNCTIONAL COMPETENCE (2019) (0)
- The Role of Sex Differences in Cortico-Striatal Functional Connectivity in Schizophrenia (2020) (0)
- PUFA Biostatus Predicts Clinical and Neuropsychological Functioning in Recent-Onset Psychosis (2020) (0)
- ENDOPHENOTYPES FOR SCHIZOPHRENIA (SZ) AND BIPOLAR DISORDER (BPD): ADDRESSING THE ISSUE OF SPECIFICITY (2008) (0)
- Anterior cingulate grey-matter deficits Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia and cannabis use in first-episode schizophrenia (2007) (0)
- SU85. The Behavioral and Neural Correlates of Social Cognition in Youth With Mental Illness (2017) (0)
- O7.2. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION IN A CLINICAL COHORT (2018) (0)
- Independent Component Analysis of Resting State fMRI in Pediatric Obsessive-Compulsive Disorder (2012) (0)
- S186. Emotional Modulation of Target Detection in Deficit and Non-Deficit Schizophrenia (2018) (0)
- Frontal lobe fALFF measured from resting-state fMRI as a prognostic biomarker in first-episode psychosis (2022) (0)
- Pemphigus Foliaceus: A Diagnostic Dilemma (2015) (0)
- O10.8. STRIATAL CONNECTIVITY IN BREAKTHROUGH PSYCHOSIS ON ANTIPSYCHOTIC MAINTENANCE: PRELIMINARY RESULTS FROM THE BAMM STUDY (2019) (0)
- Academic Highlights: Clinical Insights Into Pharmacogenetics and Schizophrenia, Part 1 [CME] (2008) (0)
- Mental Disorders in Children and Adolescents: Need and Strategies for Intervention (2005) (0)
- Knowledge, attitude, practice, dengue, awareness, vector. (2014) (0)
- Robust hierarchically organized whole-brain patterns of dysconnectivity in schizophrenia spectrum disorders observed after Personalized Intrinsic Network Topography (2022) (0)
- 34.1 SEPARABLE AND REPLICABLE NEURAL STRATEGIES DURING SOCIAL BRAIN FUNCTION IN PEOPLE WITH AND WITHOUT SEVERE MENTAL ILLNESS (2019) (0)
- P181. Cortical Similarities Between Bipolar I Disorder and Schizophrenia: A Multivariate Approach (2022) (0)
- Clinical and cortical similarities identified between bipolar disorder I and schizophrenia: A multivariate approach (2022) (0)
- 354. The effects of metabolic and cognitive stress on cerebral blood flow (1996) (0)
- Comparing the Interplay of Symptom Domains of Users and Non-Users of Cannabis Within Schizophrenia: A Network Analysis (2020) (0)
- 7. A Functional Connectome-Based Neural Signature for Individualized Prediction of Antipsychotic Response in First-Episode Psychosis (2023) (0)
- Replication of Genetic Markers Associated with Clozapine-Induced Agranulocytosis. (2006) (0)
- F198. Parahippocampal Thickness Predicts Treatment Improvement in Early and Chronic Schizophrenia (2018) (0)
- 127. Examining Subcortical-Cortical Connectivity in Schizophrenia Using Personalized Intrinsic Network Topography (2019) (0)
- The role of gender in the pharmacotherapy of schizophrenia (1995) (0)
- S20. PARAHIPPOCAMPAL THICKNESS PREDICTS TREATMENT IMPROVEMENT IN EARLY AND CHRONIC SCHIZOPHRENIA (2018) (0)
- Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals (2018) (0)
- 197. Omega-3 Polyunsaturated Fatty Acids May Protect Against White Matter Abnormalities Found in Early Phase Psychosis (2018) (0)
- The Effect of Electric Field on the Human Brain (2020) (0)
- Altered Orbitofrontal Connectivity is Associated With Subclinical Avolitional Symptoms in Healthy Adults (2021) (0)
- T23. ANTIPSYCHOTIC EXPOSURE AND STRIATAL FUNCTIONAL CONNECTIVITY IN PSYCHOSIS RELAPSE: A HYPOTHESIS GENERATING STUDY (2020) (0)
- 34. DATA-DRIVEN, LARGE N, FINDINGS FROM THE MULTI-CENTER SOCIAL PROCESSES INITIATIVE IN NEUROBIOLOGY OF THE SCHIZOPHRENIA(S) (SPINS) STUDY: IDENTIFYING NEW BRAIN-BEHAVIOR SUBGROUPS, INCLUDING AT THE INDIVIDUAL LEVEL (2019) (0)
- Genetics and Pharmacogenetics of Schizophrenia: Recent Progress (2013) (0)
- O7.1. ABNORMAL DEVELOPMENT, FAULTY MATURATION OR ACCELERATED AGING? “WHITE MATTER AT THE CENTER STAGE OF SCHIZOPHRENIA” REVISITED (2019) (0)
- Clozapine treatment in patients with chronic schizophrenia: efficacy and predictors of response (1994) (0)
- Clozapine response and allelic variation in the 5HT2A and 5HT2C receptor genes (1996) (0)
- History of childhood maltreatment is associated with reduced fractional anisotropy of the accumbofrontal ‘reward’ tract in healthy adults (2020) (0)
- Author Correction: Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function (2019) (0)
- 9. Elevated TNF-α Levels in Cerebrospinal Fluid of Patients With Schizophrenia. (2017) (0)
- O31. Age-Normative Pathways of Striatal Connectivity Relate to ADHD Symptoms in the General Population (2018) (0)
- Molecular genetics and psychopharmacology (2004) (0)
- The cognitive effects of ketamine, an NMDA antagonist, in normal controls and drug-free schizophrenic patients (1995) (0)
- Collective genomic segments with differential pleiotropic patterns between cognitive dimensions and psychopathology (2022) (0)
- 702. The Behavioural and Neural Correlates of Social Cognition in Youth with Mental Illness (2017) (0)
- Branched chain amino acids decrease top-down event-related potentials in healthy subjects (2007) (0)
- Acid C oncentration P redicts Myelin Integrity in Early-Phase Psychosis (2013) (0)
- The nuclear GAPDH-HMGB cascade in cortical microglia regulates cognitive flexibility (2022) (0)
- PHARMACOGENETIC APPROACHES TO ANTIPSYCHOTIC DRUG RESPONSE HETEROGENEITY (2008) (0)
- isrupted in Schizophrenia 1 Genotype and Positive ymptoms in Schizophrenia (2007) (0)
- 418. Heterogeneity in Functional Connectivity in Psychosis: Dimensional Predictors of Individual Variability During Rest and Task fMRI (2023) (0)
- P561. Multivariate Relationships Between Social Cognitive Performance and Functional Connectivity During Task and Rest Across Schizophrenia Spectrum Disorders and Healthy Controls (2022) (0)
- Genetics of Schizophrenia: What Do We Know: Researchers Are Discovering Clues to Predict Susceptibility, Improve Treatment (2013) (0)
- EPIDEMIOLOGY OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS OF GALL STONES DISEASE IN HIMACHAL PRADESH (2020) (0)
- Poster #T45 CHANGES IN BODY MASS AND METABOLIC PROFILES OVER 12 MONTHS IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA WITH ASSURED ANTIPSYCHOTIC ADHERENCE (2014) (0)
- NETWORK TOPOLOGY IN DEFICIT SCHIZOPHRENIA, NONDEFICIT SCHIZOPHRENIA, AND BIPOLAR DISORDER: FROM CIRCUITS TO FUNCTIONAL OUTCOME (2014) (0)
- A longitudinal multi-scanner multimodal human neuroimaging dataset (2022) (0)
- 126. Connectomes of Structural Similarity and Social Cognitive Function in Schizophrenia Spectrum Disorders (2019) (0)
- Factors Influencing Adherence to Anti-retroviral Therapy in HIV Patients Registered at ART Center Jhansi, Uttar Pradesh (2022) (0)
- Metabolic Disturbances are Associated With Impaired Social Cognition in Schizophrenia Spectrum Disorders (2020) (0)
- Multivariate Associations Among White Matter Microstructure, Neurocognition, and Social Cognition in People With a Schizophrenia Spectrum Disorder and Healthy Control Participants (2021) (0)
- In Support of Neuroimaging Biomarkers in First-Episode Schizophrenia (2018) (0)
- S157. A MULTICENTER HARMONIZED DIFFUSION TENSOR IMAGING STUDY ON THE ASSOCIATION OF WHITE MATTER STRUCTURE AND CLINICAL FUNCTIONING (2020) (0)
- 195. Fatty Acid Bioavailability and Membrane Dynamics are Associated With White Matter Integrity and Neurocognitive Performance During Development (2018) (0)
- 34.4 EXAMINING SUBCORTICAL-CORTICAL CONNECTIVITY IN SCHIZOPHRENIA USING PERSONALIZED INTRINSIC NETWORK TOPOGRAPHY (2019) (0)
- M81 SCHIZOPHRENIA POLYGENIC RISK SCORE PREDICTS ANTIPSYCHOTIC TREATMENT RESPONSE IN PATIENTS WITH FIRST EPISODE PSYCHOSIS (2019) (0)
- Characterizing Extracellular White Matter Pathologies Using Free Water Imaging Across the Schizophrenia Illness Course: A Multi-Site Harmonized Diffusion MRI Study (2021) (0)
- Water, sanitation, and hygiene practices among population living in slums, Jhansi, Uttar Pradesh, India (2017) (0)
- DTI abnormalities in pediatric obsessive compulsive disorder (2011) (0)
- Relationship among interthalamic adhesion size, thalamic anatomy and neuropsychological functions in healthy volunteers (2016) (0)
- Delineation of hippocampal subregions using T1-weighted magnetic resonance images at 3 Tesla (2014) (0)
- A cross-sectional study on factors influencing caesarean section rates in a tertiary care hospital, Jhansi (Uttar Pradesh) (2021) (0)
- Multivariate Associations Among White Matter, Neurocognition, and Social Cognition Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls. (2023) (0)
- 730. Structural and Functional Connectivity in Adolescent Psychosis (2017) (0)
- T175. The Effects of Lorazepam on Resting-State Functional Connectivity (2019) (0)
- Cognitive Therapy in Substance Abuse (2005) (0)
- A comparative study on aggression among school going adolescents of Rural and Urban Area of Jhansi (U.P.) (2015) (0)
- Alcohol and Global Burden of Disease (2005) (0)
- Missed and Lost to Follow-up Cases in HIV Positive Patients and the Impact of Lockdown During COVID-19 Pandemic on Adherence to Anti-retroviral Therapy at ART Center, Jhansi, Uttar Pradesh (2023) (0)
- Systemic Lupus Erythematosus (SLE) is not an uncommon disease (2015) (0)
- Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (2019) (0)
- Distinct Antibody Repertoire of Cerebral Spinal Fluid B Cells from Healthy Controls (2019) (0)
- Neural Activity while Imitating Emotional Faces is Related to Both Lower and Higher-Level Social Cognitive Performance (2017) (0)
- Metabolic disturbances, hemoglobin A1c, and social cognition impairment in Schizophrenia spectrum disorders (2022) (0)
- Neurocognitive performance associated with subtypes of schizoaffective disorder (2013) (0)
- Reverse pharmacogenetics: Molecular genetics in the prediction of rapid relapse following antipsychotic drug discontinuation (2000) (0)
- Suicide Ideation in Depressed People Living with HIV/AIDS in District Jhansi, Uttar Pradesh (India) (2019) (0)
- 240 Lack of association between 5HT2A, 5HT2C, and D4 receptor gene polymorphisms and the deficit syndrome of schizophrenia (1997) (0)
- Effects of the SORL1 Alzheimer's disease risk gene across the human lifespan (2013) (0)
- Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations (2023) (0)
- Contents Vol. 3, 2017 (2018) (0)
- DOPAMINE RECEPTOR GENETIC VARIATION AND ANTIPSYCHOTIC DRUG RESPONSE (2012) (0)
- 9-Year Serial Follow-up of a HIV-Positive Man With Mild Neurocognitive Deficit (2007) (0)
- THE ABNORMAL LIFE OF THE D2 RECEPTOR IN SCHIZOPHRENIA (2012) (0)
- Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function (2018) (0)
- Rare Case of Large Antesternal Goitre (2020) (0)
- Behaviour Pattern regarding HIV/AIDS among Students of Selected Professional Institutes of Ghaziabad District of Uttar Pradesh. (2018) (0)
- CANNABIS AND COGNITIVE FUNCTIONS. A RE-EVALUATION (1988) (0)
- 349. Neuroimaging Biomarkers of ECT Response (2017) (0)
- 161. The Relationship Among Electric-Field Distributions, Neuroimaging Findings and Clinical Outcomes in ECT (2019) (0)
- F99. SOCIAL COGNITIVE NETWORK CONNECTIVITY SUPPORTS A NETWORK EFFICIENCY MODEL FOR BETTER SOCIAL COGNITIVE PERFORMANCE ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS AND HEALTHY CONTROLS (2019) (0)
- Response to letter to the editor from Schulze et al.—“Is there a phenotypic difference between probands in case‐control versus family‐based association studies?” (2003) (0)
- Skin Rashes in Systemic Lupus Erythematosus (2015) (0)
- IDENTIFICATION OF NEUROIMAGING BIOMARKERS FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Anilkumar Malhotra.?
Anilkumar Malhotra. is affiliated with the following schools:
